// Therapeutic area
Orthopedics: restoring joint function, reducing pain.
We support orthopedic surgeons and sports-medicine specialists with therapies for the most common cause of disability worldwide — osteoarthritis.
01CLINICAL NEED
Osteoarthritis is the most disabling joint condition.
Progressive loss of cartilage and synovial fluid viscoelasticity drives pain, stiffness, and functional decline. Intra-articular viscosupplementation is an established, guideline-recognized option in the treatment continuum between conservative care and surgical intervention.
- Knee osteoarthritis (Kellgren–Lawrence I–III)
- Hip osteoarthritis
- Shoulder & other synovial joints
- Post-traumatic joint pain
FIG. 01TIBIOFEMORAL JOINT
02PORTFOLIO
Our orthopedic portfolio
Our current portfolio centers on intra-articular viscosupplementation, with regenerative options entering our pipeline.
Supintro
Sodium hyaluronate intra-articular injection developed by ERC Bio for symptomatic osteoarthritis.
Regenerative (upcoming)
Regenerative options for cartilage support are entering our pipeline.